Discontinued — last reported Q4 '20
Curtiss-Wright Business Sale Proceeds decreased by 62.8% to $314.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.1%, from $499.00K to $314.00K. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows a downward trend with a -25.2% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.96M | $407.00K | $656.00K | $5.57M | $752.00K | $2.79M | $731.00K | $224.00K | $249.00K | -$9.00K | $8.68M | $41.00K | $94.00K | $1.07M | $2.00M | $499.00K | -$197.00K | $122.00K | $844.00K | $314.00K |
| QoQ Change | — | -79.2% | +61.2% | +748.6% | -86.5% | +271.1% | -73.8% | -69.4% | +11.2% | -103.6% | >999% | -99.5% | +129.3% | >999% | +86.7% | -75.0% | -139.5% | +161.9% | +591.8% | -62.8% |
| YoY Change | — | — | — | — | -61.6% | +585.7% | +11.4% | -96.0% | -66.9% | -100.3% | >999% | -81.7% | -62.2% | >999% | -77.0% | >999% | -309.6% | -88.6% | -57.8% | -37.1% |